1World Health Organization (2000) Obesity: Preventing and Managing the Global Epidemic, no. 894. Geneva: WHO.
2Craig R & Mindell J (2008) Health Survey for England 2006 Latest Trends. London: The Information Centre.
3Wardle J & Boniface D (2008) Changes in the distributions of body mass index and waist circumference in English adults, 1993/1994 to 2002/2003. Int J Obes (Lond) 32, 527–532.
5Hotamisligil GS, Shargill NS & Spiegelman BM (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259, 87–91.
6Trayhurn P (2005) The biology of obesity. Proc Nutr Soc 64, 31–38.
7Hauner H (2005) Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 64, 163–169.
8Zhang Y, Proenca R, Maffei M, et al. . (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432.
9Mohamed-Ali V, Pinkney JH & Coppack SW (1998) Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 22, 1145–1158.
10Moreno-Aliaga MJ, Campión J, Milagro FI, et al. . (2005) Adiposity and proinflammatory state: the chicken or the egg. Adipocytes 1, 1–16.
11Rokling-Andersen MH, Reseland JE, Veierod MB, et al. . (2007) Effects of long-term exercise and diet intervention on plasma adipokine concentrations. Am J Clin Nutr 86, 1293–1301.
12Scherer PE, Williams S, Fogliano M, et al. . (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270, 26746–26749.
13Yudkin JS, Stehouwer CD, Emeis JJ, et al. . (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19, 972–978.
14Trayhurn P & Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92, 347–355.
15Greenberg AS & Obin MS (2006) Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83, 461S–465S.
16Das UN (2001) Is obesity an inflammatory condition? Nutrition 17, 953–966.
17Engstrom G, Hedblad B, Stavenow L, et al. . (2003) Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 52, 2097–2101.
18Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911–919.
19Hotamisligil G (2006) Inflammation and metabolic disorders. Nature 444, 860–867.
20Ahima RS & Flier JS (2000) Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11, 327–332.
21Festa A, D'Agostino R Jr, Williams K, et al. . (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25, 1407–1415.
22Cottam DR, Mattar SG, Barinas-Mitchell E, et al. . (2004) The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 14, 589–600.
23Wellen KE & Hotamisligil GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115, 1111–1119.
24Hartz AJ, Rupley DC & Rimm AA (1984) The association of girth measurements with disease in 32,856 women. Am J Epidemiol 119, 71–80.
25Ohlson LO, Larsson B, Svardsudd K, et al. . (1985) The influence of body fat distribution on the incidence of diabetes mellitus. 13·5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34, 1055–1058.
26Rimm EB, Stampfer MJ, Giovannucci E, et al. . (1995) Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 141, 1117–1127.
27Rexrode KM, Carey VJ, Hennekens CH, et al. . (1998) Abdominal adiposity and coronary heart disease in women. JAMA 280, 1843–1848.
28Janssen I, Katzmarzyk PT & Ross R (2002) Body mass index, waist circumference, and health risk: evidence in support of current National Institutes Of Health guidelines. Arch Intern Med 162, 2074–2079.
29von Eyben FE, Mouritsen E, Holm J, et al. . (2003) Intra-abdominal obesity and metabolic risk factors: a study of young adults. Int J Obes Relat Metab Disord 27, 941–949.
30Snijder MB, van Dam RM, Visser M, et al. . (2006) What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 35, 83–92.
31Fain JN (2006) Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 74, 443–477.
32Hirsch J & Batchelor B (1976) Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 5, 299–311.
33Powell K (2007) Obesity: the two faces of fat. Nature 447, 525–527.
34de Ferranti S & Mozaffarian D (2008) The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 54, 945–955.
35Spalding KL, Arner E, Westermark PO, et al. . (2008) Dynamics of fat cell turnover in humans. Nature 453, 783–787.
36Frayn KN (2005) Obesity and metabolic disease: is adipose tissue the culprit? Proc Nutr Soc 64, 7–13.
37Weisberg SP, McCann D, Desai M, et al. . (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796–1808.
38Xu H, Barnes GT, Yang Q, et al. . (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821–1830.
39Fain JN, Madan AK, Hiler ML, et al. . (2004) Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145, 2273–2282.
40Bassuk SS, Rifai N & Ridker PM (2004) High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 29, 439–493.
41Lyon CJ, Law RE & Hsueh WA (2003) Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144, 2195–2200.
42Nawrocki AR & Scherer PE (2004) The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation. Curr Opin Pharmacol 4, 281–289.
43Ronti T, Lupattelli G & Mannarino E (2006) The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 64, 355–365.
44Dietrich M & Jialal I (2005) The effect of weight loss on a stable biomarker of inflammation, C-reactive protein. Nutr Rev 63, 22–28.
45Devaraj S, Kasim-Karakas S & Jialal I (2006) The effect of weight loss and dietary fatty acids on inflammation. Curr Atheroscler Rep 8, 477–486.
46Selvin E, Paynter NP & Erlinger TP (2007) The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 167, 31–39.
47You T, Berman DM, Ryan AS, et al. . (2004) Effects of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women. J Clin Endocrinol Metab 89, 1739–1746.
48Keogh JB, Brinkworth GD & Clifton PM (2007) Effects of weight loss on a low-carbohydrate diet on flow-mediated dilatation, adhesion molecules and adiponectin. Br J Nutr 98, 852–859.
49Davì G, Guagnano MT, Ciabattoni G, et al. . (2002) Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 288, 2008–2014.
50McLaughlin T, Abbasi F, Lamendola C, et al. . (2002) Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 106, 2908–2912.
51Bougoulia M, Triantos A & Koliakos G (2006) Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women. Hormones (Athens) 5, 259–269.
52Heilbronn LK, Noakes M & Clifton PM (2001) Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 21, 968–970.
53Hannum SM, Carson L, Evans EM, et al. . (2004) Use of portion-controlled entrees enhances weight loss in women. Obes Res 12, 538–546.
54Considine RV, Sinha MK, Heiman ML, et al. . (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Eng J Med 334, 292–295.
55Bruun JM, Verdich C, Toubro S, et al. . (2003) Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-α. Effect of weight loss in obese men. Eur J Endocrinol 148, 535–542.
56Tchernof A, Nolan A, Sites CK, et al. . (2002) Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105, 564–569.
57Clément K, Viguerie N, Poitou C, et al. . (2004) Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 18, 1657–1669.
58Bastard JP, Jardel C, Bruckert E, et al. . (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85, 3338–3342.
59Raitakari M, Ilvonen T, Ahotupa M, et al. . (2004) Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol 24, 124–128.
60Heald AH, Golding C, Sharma R, et al. . (2004) A substitution model of dietary manipulation is an effective means of optimising lipid profile, reducing C-reactive protein and increasing insulin-like growth factor-1. Br J Nutr 92, 809–818.
61Brekke HK, Lenner RA, Taskinen MR, et al. . (2005) Lifestyle modification improves risk factors in type 2 diabetes relatives. Diabetes Res Clin Pract 68, 18–28.
62Kasim-Karakas SE, Tsodikov A, Singh U, et al. . (2006) Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake. Am J Clin Nutr 83, 774–779.
63O'Brien KD, Brehm BJ, Seeley RJ, et al. . (2005) Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects. J Clin Endocrinol Metab 90, 2244–2249.
64Wood RJ, Volek JS, Davis SR, et al. . (2006) Effects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease. Nutr Metab 3, 19.
65Viguerie N, Vidal H, Arner P, et al. . (2005) Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetologia 48, 123–131.
66Arvidsson E, Viguerie N, Andersson I, et al. . (2004) Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes 53, 1966–1971.
67Noakes M, Keogh JB, Foster PR, et al. . (2005) Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. Am J Clin Nutr 81, 1298–1306.
68Pereira MA, Swain J, Goldfine AB, et al. . (2004) Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA 292, 2482–2490.
69Olson TP, Dengel DR, Leon AS, et al. . (2007) Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women. Int J Obes (Lond) 31, 996–1003.
70Tsukui S, Kanda T, Nara M, et al. . (2000) Moderate-intensity regular exercise decreases serum tumor necrosis factor-α and HbA1c levels in healthy women. Int J Obes Relat Metab Disord 24, 1207–1211.
71Strączkowski M, Kowalska I, Dzienis-Straczkowska S, et al. . (2001) Changes in tumor necrosis factor-α system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance. Eur J Endocrinol 145, 273–280.
72Okita K, Nishijima H, Murakami T, et al. . (2004) Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol 24, 1868–1873.
73Ballor DL & Poehlman ET (1994) Exercise-training enhances fat-free mass preservation during diet-induced weight loss: a meta-analytical finding. Int J Obes Relat Metab Disord 18, 35–40.
74Hunter GR, Byrne NM, Sirikul B, et al. . (2008) Resistance training conserves fat-free mass and resting energy expenditure following weight loss. Obesity 16, 1045–1051.
75Itoh K, Imai K, Masuda T, et al. . (2002) Relationship between changes in serum leptin levels and blood pressure after weight loss. Hypertens Res 25, 881–886.
76Sheu WH, Chang T, Lee W, et al. . (2008) Effect of weight loss on proinflammatory state of mononuclear cells in obese women. Obesity 16, 1033–1038.
77Ryan AS & Nicklas BJ (2004) Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care 27, 1699–1705.
78Dvořáková-Lorenzová A, Suchanek P, Havel PJ, et al. . (2006) The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. Metabolism 55, 359–365.
79Salas-Salvadó J, Bullo M, Garcia-Lorda P, et al. . (2006) Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss. Int J Obes (Lond) 30, 1714–1720.
80Church TS, Willis MS, Priest EL, et al. . (2005) Obesity, macrophage migration inhibitory factor, and weight loss. Int J Obes (Lond) 29, 675–681.
81Esposito K, Giugliano F, Di Palo C, et al. . (2004) Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291, 2978–2984.
82Esposito K, Pontillo A, Di Palo C, et al. . (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. JAMA 289, 1799–1804.
83St-Onge M, Desmond R, Hunter G, et al. . (2008) Baseline inflammatory markers do not modulate the lipid response to weight loss. Metabolism 57, 598–604.
84Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M, et al. . (2000) Serum concentrations of TNF-α and soluble TNF-α receptors in obesity. Int J Obes Relat Metab Disord 24, 1392–1395.
85Ziccardi P, Nappo F, Giugliano G, et al. . (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105, 804–809.
86Nicoletti G, Giugliano G, Pontillo A, et al. . (2003) Effect of a multidisciplinary program of weight reduction on endothelial functions in obese women. J Endocrinol Invest 26, R5–R8.
87Marfella R, Esposito K, Siniscalchi M, et al. . (2004) Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women. Diabetes Care 27, 47–52.
88Dandona P, Weinstock R, Thusu K, et al. . (1998) Tumor necrosis factor-α in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 83, 2907–2910.
89Obisesan TO, Leeuwenburgh C, Phillips T, et al. . (2004) C-reactive protein genotypes affect baseline, but not exercise training-induced changes, in C-reactive protein levels. Arterioscler Thromb Vasc Biol 24, 1874–1879.
90Giugliano G, Nicoletti G, Grella E, et al. . (2004) Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg 57, 190–194.
91Klein S, Fontana L, Young VL, et al. . (2004) Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350, 2549–2557.
92Busetto L, Bassetto F, Zocchi M, et al. . (2008) The effects of the surgical removal of subcutaneous adipose tissue on energy expenditure and adipocytokine concentrations in obese women. Nutr Metab Cardiovasc Dis 18, 112–120.
93Krzyzanowska K, Mittermayer F, Kopp HP, et al. . (2004) Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J Clin Endocrinol Metab 89, 6277–6281.
94Haider DG, Schindler K, Schaller G, et al. . (2006) Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 91, 1578–1581.
95Yang W, Lee W, Funahashi T, et al. . (2001) Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86, 3815–3819.
96Laimer M, Kaser S, Kranebitter M, et al. . (2005) Effect of pronounced weight loss on the nontraditional cardiovascular risk marker matrix metalloproteinase-9 in middle-aged morbidly obese women. Int J Obes (Lond) 29, 498–501.
97Laimer M, Ebenbichler CF, Kaser S, et al. . (2002) Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord 26, 659–662.
98Hanusch-Enserer U, Cauza E, Spak M, et al. . (2004) Improvement of insulin resistance and early atherosclerosis in patients after gastric banding. Obes Res 12, 284–291.
99Kopp HP, Krzyzanowska K, Mohlig M, et al. . (2005) Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond) 29, 766–771.
100Hanusch-Enserer U, Cauza E, Spak M, et al. . (2003) Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes Relat Metab Disord 27, 355–361.
101Kopp HP, Hopp CW, Festa A, et al. . (2003) Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 23, 1042–1047.
102Kopp CW, Kopp HP, Steiner S, et al. . (2003) Weight loss reduces tissue factor in morbidly obese patients. Obes Res 11, 950–956.
103Cancello R, Henegar C, Viguerie N, et al. . (2005) Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54, 2277–2286.
104Manco M, Fernandez-Real JM, Equitani F, et al. . (2007) Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab 92, 483–490.
105Vendrell J, Broch M, Vilarrasa N, et al. . (2004) Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 12, 962–971.
106Faraj M, Havel PJ, Phelis S, et al. . (2003) Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88, 1594–1602.
107Liou JM, Lin JT, Lee WJ, et al. . (2008) The serial changes of ghrelin and leptin levels and their relations to weight loss after laparoscopic minigastric bypass surgery. Obes Surg 18, 84–89.
108Hulver MW, Zheng D, Tanner CJ, et al. . (2002) Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 283, E861–E865.
109Calvani M, Scarfone A, Granato L, et al. . (2004) Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes 53, 939–947.
110van Dielen FM, Buurman WA, Hadfoune M, et al. . (2004) Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab 89, 4062–4068.
111Poitou C, Coussieu C, Rouault C, et al. . (2006) Serum amyloid A: a marker of adiposity-induced low-grade inflammation but not of metabolic status. Obesity (Silver Spring) 14, 309–318.
112Vázquez LA, Pazos F, Berrazueta JR, et al. . (2005) Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 90, 316–322.
113Gannagé-Yared M, Yaghi C, Habre B, et al. . (2008) Osteoprotegerin in relation to body weight, lipid parameters, insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study. Eur J Endocrinol 158, 353–359.
114Botella-Carretero JI, Alvarez-Blasco F, Martinez-Garcia MA, et al. . (2007) The decrease in serum IL-18 levels after bariatric surgery in morbidly obese women is a time-dependent event. Obes Surg 17, 1199–1208.
115Madsen EL, Rissanen A, Bruun JM, et al. . (2008) Weight loss larger than 10 % is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Eur J Endocrinol 158, 179–187.
116Magro DL, Geloneze B, Delfini R, et al. . (2008) Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg 18, 648–651.
117Lean ME, Han TS & Morrison CE (1995) Waist circumference as a measure for indicating need for weight management. BMJ 311, 158–161.
118Han TS, van Leer EM, Seidell JC, et al. . (1995) Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311, 1401–1405.
119Anonymous (1998) Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults – The Evidence Report. National Institutes of Health. Obes Res 6, Suppl. 2, 51S–209S.
120Lemieux I, Pascot A, Prud'homme D, et al. . (2001) Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 21, 961–967.
121Chaston TB & Dixon JB (2008) Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review. Int J Obes (Lond) 32, 619–628.
122Clifton PM (2003) Diet and C-reactive protein. Curr Atheroscler Rep 5, 431–436.
123Albert MA, Glynn RJ & Ridker PM (2003) Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation 108, 161–165.
124Thorand B, Baumert J, Döring A, et al. . (2006) Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 184, 216–224.
125Ridker PM, Hennekens CH, Rifai N, et al. . (1999) Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 100, 713–716.
126Pradhan AD, Manson JE, Rossouw JE, et al. . (2002) Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 288, 980–987.
127Minderico CS, Silva AM, Keller K, et al. . (2008) Usefulness of different techniques for measuring body composition changes during weight loss in overweight and obese women. Br J Nutr 99, 432–441.
128Webster JD, Hesp R & Garrow JS (1984) The composition of excess weight in obese women estimated by body density, total body water and total body potassium. Hum Nutr Clin Nutr 38, 299–306.
129Cole TJ, Fewtrell MS & Prentice A (2008) The fallacy of using percentage body fat as a measure of adiposity. Am J Clin Nutr 87, 1959.
130VanItallie TB, Yang M, Heymsfield SB, et al. . (1990) Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr 52, 953–959.
131Schutz Y, Kyle UU & Pichard C (2002) Fat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y. Int J Obes Relat Metab Disord 26, 953–960.
132Kyle UG, Schutz Y, Dupertuis YM, et al. . (2003) Body composition interpretation: contributions of the fat-free mass index and the body fat mass index. Nutrition 19, 597–604.
133Kyle UG, Genton L, Gremion G, et al. . (2004) Aging, physical activity and height-normalized body composition parameters. Clin Nutr 23, 79–88.
134Forsythe LK, Livingstone MBE, Barnes MS, et al. . (2008) C-reactive protein and body composition in a representative sample of young adults. Proc Nutr Soc .